HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancer.

Abstract
The purpose of this study was to determine the anticancer efficacy of 1,1-bis (3'-indolyl)-1-(p-biphenyl) methane (DIM-C-pPhC₆H₅) by inhalation delivery alone and in combination with i.v. docetaxel in a murine model for lung cancer. An aqueous DIM-C-pPhC₆H₅ formulation was characterized for its aerodynamic properties. Tumor-bearing athymic nude mice were exposed to nebulized DIM-C-pPhC₆H₅, docetaxel, or combination (DIM-C-pPhC₆H₅ plus docetaxel) using a nose-only exposure technique. The aerodynamic properties included mass median aerodynamic diameter of 1.8 ± 0.3 μm and geometric SD of 2.31 ± 0.02. Lung weight reduction in mice treated with the drug combination was 64% compared with 40% and 47% in mice treated with DIM-C-pPhC₆H₅ aerosol and docetaxel alone, respectively. Combination treatment decreased expression of Akt, cyclin D1, survivin, Mcl-1, NF-κB, IκBα, phospho-IκBα, and vascular endothelial growth factor (VEGF) and increased expression of c-Jun NH₂-terminal kinase 2 and Bad compared with tumors collected from single-agent treatment and control groups. DNA fragmentation was also enhanced in mice treated with the drug combination compared with docetaxel or DIM-C-pPhC₆H₅ alone. Combination treatment decreased expressions of VEGF and CD31 compared with single-agent treated and control groups. These results suggest that DIM-C-pPhC₆H₅ aerosol enhanced the anticancer activity of docetaxel in a lung cancer model by activating multiple signaling pathways. The study provides evidence that DIM-C-pPhC₆H₅ can be used alone or in combination with other drugs for the treatment of lung cancer using the inhalation delivery approach.
AuthorsNkechi Ichite, Mahavir Chougule, Apurva R Patel, Tanise Jackson, Stephen Safe, Mandip Singh
JournalMolecular cancer therapeutics (Mol Cancer Ther) Vol. 9 Issue 11 Pg. 3003-14 (Nov 2010) ISSN: 1538-8514 [Electronic] United States
PMID20978159 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright©2010 AACR.
Chemical References
  • 1,1-bis(3'-indolyl)-1-(4-biphenyl)methane
  • Antineoplastic Agents
  • Indoles
  • Nasal Sprays
  • 3,3'-diindolylmethane
Topics
  • Administration, Inhalation
  • Animals
  • Antineoplastic Agents (administration & dosage, adverse effects)
  • Carcinoma, Non-Small-Cell Lung (drug therapy, pathology)
  • Cell Line, Tumor
  • Drug Delivery Systems
  • Female
  • Humans
  • Indoles (administration & dosage, adverse effects, chemistry)
  • Lung Neoplasms (drug therapy, pathology)
  • Mice
  • Mice, Nude
  • Models, Biological
  • Nasal Sprays
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: